DENTSPLY SIRONA Inc. (XRAY) Form 10-Q — Aug 6, 2026

$XRAYForm 10-QFiled Aug 6, 2026, 4:56 PM ET0000818479-26-000255Original filing

Dentsply Sirona's 10-Q for the quarter ended June 30, 2026 reports net sales of $898 million, down from $936 million a year earlier, while the company swung to net income of $37 million ($0.18 diluted EPS) from a $45 million loss in Q2 2025. First-half sales were $1,778 million with net income of $27 million, with the steepest segment decline in Orthodontic and Implant Solutions (sales $197M vs $226M, including Orthodontics at $40M vs $63M). The quarter's profitability was boosted by approximately $44 million of one-time refunds of U.S. tariffs paid under IEEPA, which also lifted H1 operating cash flow to $139 million from $55 million.

Key figures

Eps: $0.18 diluted Q2 2026 (vs $(0.22) Q2 2025); $0.14 H1 2026
Revenue: $898M Q2 2026 (vs $936M Q2 2025); $1,778M H1 2026 (vs $1,815M H1 2025)
Net Income: $37M Q2 2026 attributable to Dentsply Sirona (vs $(45)M loss Q2 2025); $27M H1 2026
Total Debt: ≈$2,224M ($228M notes payable/current portion + $1,996M long-term debt)
Revenue Yoy: ≈-4% Q2 YoY (derived: $898M vs $936M)
Total Assets: $5,204M
Cash Position: $239M at June 30, 2026 (vs $326M at Dec 31, 2025)
Shares Outstanding: 199353876
Dividend: quarterly dividend eliminated starting Q1 2026 (was $0.16/share)
Q2 buybacks: 1.3M shares for $12M (avg $9.94/share); $1.2B authorization remaining
Capex h1 2026: $96M; FY2026 guidance $140M-$160M
Segment sales q2 2026: CTS $239M, EDS $376M, OIS $197M (Orthodontics $40M vs $63M), Wellspect $86M
Russia cash restricted: $57M
Tariff refunds q2 2026: $44M IEEPA refunds received
Operating cash flow h1 2026: $139M (vs $55M prior-year period)
Commercial paper outstanding: $35M at June 30, 2026
Restructuring total expected: $60M-$65M
Restructuring charges to date: $57M under 2026 Plan
Byte intangible amortization increase: ≈$14M incremental in Q2 2026 from shortened useful life
Restructuring annualized savings target: $120M

Price after filing

1 day: -3.4%7 days: -18.9%30 days: -20.3%

Close on the filing date to close N calendar days later (from $14.27). Historical, not a forecast.

AI analysis

Red flags9 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.